How Can We Help You?


Quick Info:

Find a Doctor Specialties (800) 213-3284

Go To Home PageBack


Select Clinical Trial

Protocol Number: Matisse C3671008, NCT04424316

Protocol Title:  Phase 3, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of a Respiratory Syncytial Virus (RSV) Pre-Fusion F Subunit Vaccine in Infants Born to Women Vaccinated During Pregnancy

Eligibility: Pregnant women age 18 and older, 24-36 weeks gestation with estimated delivery dates before February 12, 2021.

Contact Information: (910) 715-2200

Clara McLean House
Make a Donation
News & Events